Trial Profile
A study investigating pharmacokinetics of efavirenz in HIV infected pregnant women with or without tuberculosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2021
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Efavirenz/lamivudine/zidovudine (Primary) ; Emtricitabine (Primary) ; Nevirapine (Primary) ; Tenofovir (Primary) ; Zidovudine (Primary) ; Isoniazid; Rifampicin
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms TSHEPISO
- 15 Mar 2021 Results by taking samples from Tshepiso cohort, assessing whether plasma kynurenine-totryptophan ratio could be used to diagnose active TB among HIV-infected pregnant women, published in the Clinical Infectious Diseases
- 07 Dec 2015 New trial record